The mS9 DNA Colorectal Cancer Screening Test is intended for detecting the presence of methylated Septin 9 (mS9) DNA in the cancer patient blood, which is associated with cancerous cells of colon cancer present within the body. There is an increased level of methylated Septin 9 DNA and cells circulating in the blood of cancer patients compared to healthy controls and this can be used as a useful biomarker for colon cancer detection.
The test was designed to specifically detect the mS9 DNA in blood plasma and serves as an early warning indicator that further confirmation with colonoscopy will be necessary. Screening means examining individual without symptoms in order to detect disease or find individual at increased risk of disease.
"Silver Winner - Health Care Services" in "2015 W3 Awards"